Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ENPP1 inhibitor TXN-10128 shows promising antitumor activity trough restoration of STING activation

Oct. 13, 2021

BRD9 is a druggable target for treating ccRCC with absent or low HIF-2alpha expression

Oct. 13, 2021

NVL-520 demonstrates efficacy in PDX models harboring ROS1 fusions

Oct. 13, 2021

Preclinical data presented for RP-3500

Oct. 13, 2021

New TRK inhibitors divulged by J2H Biotech

Oct. 13, 2021

Atux Iskay presents new anticancer compounds

Oct. 13, 2021

Discovery and preclinical characterization of novel TLR3 agonist, TL-532

Oct. 13, 2021

Glycogen phosphorylase identified as a therapeutic target for anaplastic thyroid cancer

Oct. 11, 2021

Filling the glass by emptying cancer cells' plates

Oct. 11, 2021

Mirati Therapeutics describes discovery and activity of GTPase KRAS inhibitor MRTX-1133

Oct. 11, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...